|
|
| |
|
|
|
|
MISSION
To Excel in the provision of effective and dynamic
healthcare delivery through the manufacturing of
high quality pharmaceutical products, education,
medical services and research.
Gemini Pharmaceuticals Nigeria Limited was incorporated
in 1972 by Bayer A.G. Leverkusen, and Dr. M. B.
Unuane with so objective to market and manufacture
Bayer AG's Pharmaceutical Specialties in Nigeria.
At the inception, 60% of its shares was owned by
Bayer AG Leverkusen, West Germany and 40% by Nigerians.
In 1974, a Joint Venture agreement was signed between
Dr. M. B. Unuane, Dr. T. A. Odutola and Bayer AG,
Leverkusen. The name was changed to Bayer Pharmaceuticals
Nigeria Limited. The then company acquired 12 acres
of land at Apapa / Oshodi Express Amuwo-Odofin,
Lagos for the purpose of erecting Pharmaceutical
Manufacturing Company. The ultra modern factory
was commissioned in 1982. Commercial activities
also commenced the same year.
In the late 80’s, Bayer A.G., as part of its
global policy decided to disengage from its activities
in the third world countries to allow indigenes
to own and manage their subsidiary companies. The
share of Bayer AG and Dr.T. A. Odutola was acquired
by DR. M. B. UNUANE and the company was formally
handed to him on 30th June 1993. It reversed to
its original name "Gemini Pharmaceutical Nigeria
Limited". With a Franchise and Licence Agreement,
to continue to manufacture Bayer AG Pharmaceutical
Specialist in Nigeria until 2002.
STRATEGIC FOCUS
CORPORATE IMAGE
(i) To project GEMINI PHARMACEUTICALS NIGERIA LIMITED
to her customers as the one company with a heritage
of quality and trust that cannot be diluted and
ensure that her customers are delighted with the
world class quality of its brands through intense
quality assurance and world class GMP.
(ii) To make GEMINI PHARMACEUTICALS a household
name in Nigeria.
OBJECTIVES
(i) Consistently maintain Good Manufacturing Practice
in accordance to highest international standard.
(ii) To ensure that the products are available through
effective distribution channels.
(iii) To strengthen the image of GEMINI PHARMACEUTICALS
NIGERIA LIMITED in Nigeria, and our operations in
different parts of Africa and Worldwide amongst
medical professions, distributors and customers
through the provision of best in class pharmaceutical
products.
(iv) To continue medical education by way of medical
representation, symposia and sponsorship of medical
and pharmaceutical conferences in Nigeria and in
countries where we currently have operations.
(v) To consolidate and expand the market positions
of GEMINI products in Nigeria, Africa, Caribbean
and indeed worldwide.
(vi) Train and retrain our people to meet human
development objectives of the company and ensure
that they have the relevant skill to get the job
done. Key staff in the system would undergo training
and retraining in Nigeria and overseas.
(vii) Sourcing and products diversification from
GEMINI PHARMACEUTICALS NIGERIA LIMITED to satisfy
different segments of the market.
(viii) For market diversification and product opportunities,
generics production would have an emphasis including
other Gemini Pharmaceuticals Nigeria Limited product
lines as the market dictates.
|
|
|
|
|
|
|
|
